Angiogenesis Inhibition: State of the Art, Forgotten Strategies and New Perspectives in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|5|3|203-216

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.5, Iss.3, 2009-08, pp. : 203-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Strategies for Triple Negative Breast Cancer: ‘State-of-the-art’ and Future Perspectives

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 6, 2013-07 ,pp. : 872-886

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 9-18

Bentham Science Publishers

Access to resources Recommend Favorite

Renal Cell Cancer: State of the Art in Adjuvant Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 242-250

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis Inhibition in the Treatment of Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1070-1078

Bentham Science Publishers

Access to resources Recommend Favorite